Press Release

2022-09-02  BioEcho Life Sciences announces expansion with new US subsidiary

2022-09-02 BioEcho Life Sciences announces expansion with new US subsidiary

The BioEcho subsidiary in the biotechnology hub of Boston is a decisive step in the company’s plan to serve a worldwide growing customer base with best-in-class products and services. The company is a specialized solution provider for the extraction and analysis of nucleic acids. BioEcho Life Sciences Inc. will be operational from 1st of September 2022.
2022-03-01

2022-03-01

BioEcho Receives Growth Equity Investment from Ampersand

BioEcho announced a minority investment from Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors.
2022-03-21

2022-03-21

The Nucleic Acid Experts – Certified Twice!

BioEcho achieves two important milestones for its quality management: DIN EN ISO 9001:2015 and DIN EN ISO 13485:2016.

Sign up now!
For exclusive application notes, event tipps, opportunities, and new product announcements. Our newsletter is sent ~ 4x per year.
Newsletter